Journal article

Double-blind, placebo-controlled study on the effect of the aldosterone receptor antagonist spironolactone in patients who have persistent proteinuria and are on long-term angiotensin-converting enzyme inhibitor therapy, with or without an angiotensin II receptor blocker

Anastasia Chrysostomou, Eugenia Pedagogos, Lachlan MacGregor, Gavin J Becker

Clinical Journal of the American Society of Nephrology | AMER SOC NEPHROLOGY | Published : 2006